Citigroup Maintains Buy on CME Gr, Raises Price Target to $255
Portfolio Pulse from Benzinga Newsdesk
Citigroup analyst Christopher Allen maintains a Buy rating on CME Group and raises the price target from $250 to $255.
October 24, 2024 | 1:39 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Citigroup analyst Christopher Allen has reaffirmed a Buy rating on CME Group and increased the price target from $250 to $255, indicating a positive outlook.
The reaffirmation of a Buy rating and an increase in the price target by a major financial institution like Citigroup suggests confidence in CME Group's future performance, likely leading to a positive short-term impact on its stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100